Ulrich Karl Walter Spengler
Chief Executive Officer at altona Diagnostics GmbH
Profile
Ulrich Karl Walter Spengler is the Co-Managing Director and founder of altona Diagnostics GmbH since 1998.
He is also the founder of Artus GmbH.
Personaldienst.
Currently, he is the Co-Chief Executive Officer of altona Diagnostics Holding GmbH, Director of 2cureX ApS, Director of LISCO Beteiligungs - Und Beratungsgesellschaft mbH, and Director of Altona Diagnostics UK Ltd.
He previously served as Director of 2cureX AB from 2017 to 2019.
Ulrich Karl Walter Spengler active positions
| Companies | Position | Start |
|---|---|---|
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Director/Board Member | 2012-12-31 |
| LISCO Beteiligungs - Und Beratungsgesellschaft mbH | Director/Board Member | - |
altona Diagnostics GmbH
 altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Chief Executive Officer | 1997-12-31 |
Altona Diagnostics UK Ltd.
 Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Director/Board Member | 2017-02-26 |
Former positions of Ulrich Karl Walter Spengler
| Companies | Position | End |
|---|---|---|
| 2CUREX AB | Director/Board Member | 2019-04-01 |
| Artus GmbH Personaldienst | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| 2CUREX AB | Health Technology |
| Private companies | 5 |
|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
| LISCO Beteiligungs - Und Beratungsgesellschaft mbH | |
altona Diagnostics GmbH
altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Health Technology |
| Artus GmbH Personaldienst | Commercial Services |
Altona Diagnostics UK Ltd.
Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Health Technology |
- Stock Market
- Insiders
- Ulrich Karl Walter Spengler